Summary
The sequence of development and regression of several abnormalities of T-KK mice was studied in comparison with C57BL/6 mice. Food intake, body weights, blood sugars and plasma insulins were determined at approximately monthly intervals from 2–16 months. Insulin sensitivity, glucose tolerance andin vivo gluconeogenesis were studied at about 2 months, 5–6 months and at one year. Plasma growth hormone and glucose oxidation by isolated islets were also studied and determination of life span was made. — It was not possible to determine which abnormality occurred first in the T-KK mouse, since at 2 months significant changes in all parameters were already present. The reversal of plasma insulin and blood glucose occurred before the decreased food intake and body weights. These results were interpreted to mean that the changes in insulin and glucose may be under genetic control. — Insulin sensitivity and tolerance to glucose decreased andin vivo gluconeogenesis increased when the T-KK mice were obese, hyperglycemic and hyperinsulinemic. These changes reverted to normal after the animals lost weight and blood sugars and plasma insulin had returned to normal. Survival dropped in T-KK mice and these earlier deaths appeared to coincide with normalization of body weight, blood sugar and plasma insulin. These observations indicated that the abnormalities in the T-KK mouse are of importance to survival. — Plasma growth hormone was decreased in the fasted T-KK mice and there was no difference from normal when animals were fed. Therefore, an increase in growth hormone does not play a role in the pathogenesis of abnormalities in the T-KK mouse. Oxidation of glucose-1-14 C and -6-14C in isolated islets from T-KK mice was increased therefore confirming the hyperactivity of the islets.
Article PDF
Similar content being viewed by others
References
Kondo, K.K., Nozawa, T., Tomida, T., Ezaki, K.: Inbred strains resulting from Japanese mice. Bull. exp. Animals6, 107–112 (1957)
Nakamura, M.: A diabetic strain of the mouse. Proc. Jap. Acad.38, 348–352 (1962)
Nakamura, M., Yamada, K.: Studies on a diabetic (KK) strain of mouse. Diabetologia3, 212–221 (1967)
Nakamura, M.: Estimation of the adenohypophysial growth hormone control in the diabetic “KK” mouse strain by acrylamide gel electrophoresis. Proc. Jap. Acad.42, 512–516 (1966)
Dulin, W.E., Wyse, B.M.: Insulin secretion in early diabetic animals,in vivo studies. In: Early Diabetes. Camerini-Davalos, R., Cole, H.S. (eds.) pp. 71–77. New York and London: Academic Press 1970
Butler, L.: The inheritance of glucosuria in the KK and Ay mouse. Canad. J. Genet. Cytol.14, 265–269 (1972)
Iwatsuka, H., Shino, A., Suzuaki, Z.: General survey of diabetic features of yellow KK mice. Endocr. jap.17, 23–25 (1970)
Matsuo, T., Shino, A., Iwatsuka, H., Suzuoki, Z.: Induction of overt diabetes in KK mice by dietary means. Endocr. jap.17, 477–488 (1970)
Matsuo, T., Furumo, K., Shimakawa, K.: Factors affecting development of hyperglycemia in KK mice. J. Takeda Res. Lab.30, 307–313 (1971)
Appel, M.C., Chang, A.Y., Dulin, W.E.: Diabetes in the Toronto-KK hybrid mouse. Abnormalities in liver and pancreatic islets of Langerhans. Diabetologia10, 625–632 (1974)
Iwatsuka, H., Shino, A.: Studies on diabetic action of obesity in mice: congenital insulin resistance of KK mice. Endocr. jap.17, 535–540 (1970)
Iwatsuka, H., Matsuo, T., Shino, A., Suzuoki, Z.: Metabolic disturbance of KK mice in chemical diabetes. J. Takeda Res. Lab.29, 685–692 (1970)
Dulin, W.E., Wyse, B.M.: Diabetes in the KK mouse. Diabetologia6, 317–323 (1970)
Gerritsen, G.C., Dulin, W.E.: Effect of a new hypoglycemic agent, 3,5-dimethylpyrazole on carbohydrate and free fatty acid metabolism. Diabetes14, 507–515 (1965)
Zaharto, D.S., Beck, L.V.: Studies of a simplified plasma insulin immunoassay using cellulose powder. Diabetes17, 444–457 (1968)
Schalch, D.S., Reichlin, S.: Plasma growth hormone concentration in rat determined by radioimmunoassay. Endocrinology79, 274–280 (1966)
Schindler, W.J., Hutchins, M.O., Sepimus, E.J.: Growth hormone secretion and control in the mouse. Endocrinology91, 483–490 (1972)
Niswender, G.D., Reichert, L.E., Jr., Midgley, A.R., Nalbandov, A. V.: Radioimmunoassay for bovine and ovine luteinizing hormone. Endocrinology84, 1166–1173 (1969)
Schalch, D.A.: Use of I125 labelling in radioimmunoassay. Proc. Soc. exp. Biol. (N.Y.)121, 1279–1280 (1966)
Greenwood, F.C., Hunter, W.M.: The preparation of I131-labelled human growth hormone of high specific radioactivity. Biochem. J.89, 114–123 (1963)
Cutler, S.J., Ederer, F.: Maximum utilization of the life table method in analyzing survival. J. chron. Dis.8, 699–712 (1958)
Chang, A.Y., Schneider, D.I.: Metabolic abnormalities in the pancreatic islets and livers of the diabetic Chinese hamster. Diabetologia6, 180–185 (1970)
Miller, W.L., Krake, J.J., Vander Brook, M.J.: Studies on the utilization of uniformily labeled C14-glucose by rats given tolbutamide (Orinase). J. Pharmacol. exp. Therap.119, 513–521 (1957)
Ashmore, J., Cahill, G.F., Earle, S.A.: Studies on the disposition of isotopic glucosein vivo andin vitro under the influence of sulfonylureas. Ann. N.Y. Acad. Sci.71, 131–140 (1957)
Friedman, B., Goodman, E.H., Weinhouse, S.: Effects of insulin and fatty acids in gluconeogenesis in the rat. J. biol. Chem.242, 3620–3627 (1967)
Friedemann, B., Goodman, E.H., Weinhause, S.: Dietary and hormonal effect on gluconeogenesis and glycogenesis from pyruvate-3-14C, fructose-U-14C and glycerol-2-14C in the rat. Endocrinology86, 1267–1271 (1970)
Lacy, P.E., Kostianovsky, M.: Methods for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes16, 35–39 (1967)
Herberg, L., Major, E., Hennigs, U., Grüneklee, G., Freytag, G., Gries, F.A.: Differences in the development of the obese-hyperglycemic syndrome in obob and NZO mice. Diabetologia6, 292–299 (1970)
Bray, G.A., York, D.A.: Genetically transmitted obesity in rodents. Physiol. Rev.51, 598–646 (1971)
Cahill, G.F., Jones, E.E., Lauris, V., Steinke, J., Soeldner, J.S.: Studies on experimental diabetes in the Wellesley hybrid mouse. Diabetologia3, 171–174 (1967)
Frohman, L.A., Goldman, J.K., Bernardia, L.L.: Studies of insulin sensitivityin vivo in weanling rats with hypothalmic obesity. Metabolism21, 1133–1142 (1972)
Barrd, J.D., Hunter, W.M.: The relationship between human growth hormone and the development of diabetes mellitus and its complications. Postgrad. med. J.49, (Suppl. 1) 132–140 (1973)
Assan, R., Tchobroutsky, G.: Serial plasma growth hormone levels in 33 cases of severe diabetic ketoacidosis. Effects of sodium nicotinate. Horm. Metab. Rev.4, 317–321 (1972)
Johansen, K., Hansen, A.P.: High 24 h level of serum growth hormone in juvenile diabetics. Brit. med. J.1969 II, 556–557
Campbell, J.: Diabetogenic actions of growth hormone. In: Hypophyseal Growth Hormone, Nature and Actions. Smith, R.W., Gaebler, O.H., Long, C.N.H. (eds.) pp. 270–285. New York: McGraw Hill Book Co., Inc., The Blackiston Division 1955
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wyse, B.M., Dulin, W.E. Further characterization of diabetes-like abnormalities in the T-KK mouse. Diabetologia 10 (Suppl 1), 617–623 (1974). https://doi.org/10.1007/BF01221995
Issue Date:
DOI: https://doi.org/10.1007/BF01221995